Alpine Global Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-401	Closed	-$40	–	598
2022 Q1	$40	Sell	401 -233	-37%	-$23	0.01%	321
2021 Q4	$99K	Buy	+634	New	+$99K	0.01%	644
2021 Q2	–	Sell	-426	Closed	-$172K	–	344
2021 Q1	$172K	Buy	+426	New	+$172K	0.02%	260